SU
Suvadra Urmila Saha
About Suvadra Urmila Saha
Data last updated:
Suvadra Urmila Saha is a Director at Phylax Pharmaceuticals Private Limited (since 2018) and Director at Sushrusha Diagnostics Private Limited (since 2020). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1.43 Cr; the largest is Phylax Pharmaceuticals Private Limited at ₹1.41 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Phylax Pharmaceuticals Private Limited U24100WB2012PTC181438 | Director | 18 Aug 2018 | 2012 | ₹1.41 Cr (FY 2025) | Active |
| Sushrusha Diagnostics Private Limited U85110WB2020PTC239481 | Director | 05 Sep 2020 | 2020 | ₹2.2 Lakh (FY 2022) | Active |
Board colleagues of Suvadra Urmila Saha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deba Prasad Saha | 05224664 | Phylax Pharmaceuticals Private Limited , Sushrusha Diagnostics Private Limited | Director |
| Satya Prasad Saha | 05224612 | Phylax Pharmaceuticals Private Limited , Sushrusha Diagnostics Private Limited | Whole-Time Director |
| Urmi Saha | 05224651 | Phylax Pharmaceuticals Private Limited , Sushrusha Diagnostics Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suvadra Urmila Saha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suvadra Urmila Saha
Suvadra Urmila Saha currently holds 2 directorships: Phylax Pharmaceuticals Private Limited (Director, since 18 Aug 2018, revenue ₹1.41 Cr (FY 2025)); Sushrusha Diagnostics Private Limited (Director, since 05 Sep 2020, revenue ₹2.2 Lakh (FY 2022)).
Suvadra Urmila Saha was first appointed on 18 Aug 2018 as Director at Phylax Pharmaceuticals Private Limited. The most recent appointment on record is 05 Sep 2020 at Sushrusha Diagnostics Private Limited.
The 2 current companies of Suvadra Urmila Saha that report revenue have a combined latest revenue of ₹1.43 Cr: Phylax Pharmaceuticals Private Limited ₹1.41 Cr (FY 2025); Sushrusha Diagnostics Private Limited ₹2.2 Lakh (FY 2022).
The current boards of Suvadra Urmila Saha's companies include Deba Prasad Saha (Phylax Pharmaceuticals Private Limited), Satya Prasad Saha (Phylax Pharmaceuticals Private Limited), Urmi Saha (Phylax Pharmaceuticals Private Limited).